menu
    • menu

    Company profile for Celcuity

    NEW Drugs in Dev: 1
    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    Sharp is a leader in commercial packaging, clinical services, and sterile manufacturing.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    As a CDMO, Mikart offers integrated CDMO services for Solid Dose & Non-sterile Liquid formulations.

    Virtual Booth

    Contact Supplier

    Trusted Global CDMO Partner Delivering End-to-End Pharma Manufacturing & Development Solutions.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Celcuity was founded in 2012 by Brian Sullivan and Lance Laing, PhD, to develop a better way to diagnose and treat the cellular abnormalities that drive tumor growth. Our team of drug development scientists, biochemists, molecular biologists, and diagnostics experts are advancing new targeted therapies for cancer using an integrated therapeutic and companion diagnostic strategy that leverages our CELsignia platform. This allow...
    Celcuity was founded in 2012 by Brian Sullivan and Lance Laing, PhD, to develop a better way to diagnose and treat the cellular abnormalities that drive tumor growth. Our team of drug development scientists, biochemists, molecular biologists, and diagnostics experts are advancing new targeted therapies for cancer using an integrated therapeutic and companion diagnostic strategy that leverages our CELsignia platform. This allows Celcuity to discover new cancer sub-types molecular diagnostics cannot detect.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    CelcuityUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    16305 – 36th Avenue North Suite 100 Minneapolis, MN 55446
    Telephone
    Telephone
    763-473-0341
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.celcuity.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/celcuity/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    PEGS Boston Summit

    PEGS Boston Summit

    Not Confirmed

    envelop Contact Supplier

    PEGS Boston Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Celcuity Schedules Q1 2026 Results Release and Webcast
    Celcuity Schedules Q1 2026 Results Release and Webcast

    07 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/07/3289927/0/en/celcuity-schedules-release-of-first-quarter-2026-financial-results-and-webcast-conference-call.html

    GLOBENEWSWIRE
    07 May 2026
    Share Share
    Celcuity’s gedatolisib beats Novartis’ Piqray in phase 3
    Celcuity’s gedatolisib beats Novartis’ Piqray in phase 3

    05 May 2026

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/celcuitys-gedatolisib-beats-novartis-piqray-phase-3-breast-cancer-study

    FIERCE BIOTECH
    05 May 2026
    Share Share
    Celcuity's VIKTORIA-1 Phase 3 Trial Hits Primary Endpoint
    Celcuity's VIKTORIA-1 Phase 3 Trial Hits Primary Endpoint

    01 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/01/3286249/0/en/celcuity-s-phase-3-viktoria-1-trial-achieves-primary-endpoint-with-clinically-meaningful-improvement-in-progression-free-survival-in-pik3ca-mutant-cohort.html

    GLOBENEWSWIRE
    01 May 2026
    Share Share
    Celcuity Reports 2025 Financial Results And Corporate Update
    Celcuity Reports 2025 Financial Results And Corporate Update

    25 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/25/3262558/0/en/Celcuity-Inc-Reports-Release-of-Fourth-Quarter-and-Full-Year-2025-Financial-Results-and-Provides-Corporate-Update.html

    GLOBENEWSWIRE
    25 Mar 2026
    Share Share
    Celcuity Schedules Q4 2025 & FY Earnings Call
    Celcuity Schedules Q4 2025 & FY Earnings Call

    18 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/18/3258100/0/en/Celcuity-Schedules-Release-of-Fourth-Quarter-and-Full-Year-2025-Financial-Results-and-Webcast-Conference-Call.html

    GLOBENEWSWIRE
    18 Mar 2026
    Share Share
    Celcuity Publishes Phase 3 Gedatolisib Study Results
    Celcuity Publishes Phase 3 Gedatolisib Study Results

    09 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/09/3252366/0/en/Celcuity-Announces-Publication-of-Results-from-PIK3CA-Wild-Type-Cohort-of-Phase-3-VIKTORIA-1-Study-of-Gedatolisib-Regimens-in-HR-HER2-Advanced-Breast-Cancer-in-Journal-of-Clinical-.html

    GLOBENEWSWIRE
    09 Mar 2026
    Share Share

    ABOUT THIS PAGE

    Contact Celcuity and get a quotation

    Celcuity is a supplier offers 1 products (APIs, Excipients or Intermediates).

    Find Gedatolisib bulk offered by Celcuity

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search